German politicians advocate for a ‘right to be forgotten’ policy to protect cancer survivors from discrimination in insurance, loans, and jobs.
German politicians advocate for a ‘right to be forgotten’ policy to protect cancer survivors from discrimination in insurance, loans, and jobs.
In Germany, a growing concern about discrimination faced by cancer survivors has sparked political action. Campaigners argue that individuals who have overcome cancer encounter significant challenges, particularly when applying for bank loans, insurance, and in the adoption process.
A central proposal pushing for change comes from German politicians who have themselves battled cancer. This group is advocating for a policy known as the “right to be forgotten” (RTBF), which would allow survivors to move forward without the stigma attached to their previous diagnoses.
The initiative is particularly impactful for an estimated 5.5 million former patients in Germany, urging that once a person is medically cleared by their healthcare provider, they should not be permanently disadvantaged in life’s critical areas.
Drafted by the Social Democrats (SPD), the proposed policy suggests that after a medically justified waiting period—commonly five years—survivors should not be obligated to disclose their past cancer diagnosis when seeking insurance or loans.
One prominent advocate for this proposal is Adis Ahmetović, the SPD’s foreign policy spokesperson, who, at just 30, publicly shared his battle with lymphoma. Now 33, he has been tumor-free since October 2024 and awaits full remission status in 2029. He emphasizes that this policy would not incur any costs for the state.
Manuela Schwesig, a fellow Social Democrat and breast cancer survivor who serves as the state premier of Mecklenburg-Western Pomerania, supports the initiative. Schwesig points out that Germany lags behind other EU nations in providing the necessary protections, asserting the right for survivors to rebuild their lives without barriers.
Lars Klingbeil, SPD co-leader and current finance minister, also urges that cancer survivors be allowed to look ahead freely—both socially and economically—after overcoming their health challenges.
A petition advocating for the RTBF reforms has already amassed over 55,000 signatures. This movement was started by Tobias Burggraf, whose daughter was diagnosed with cancer at just two and a half years old.
According to a survey by a patients’ rights group, a staggering 77% of cancer survivors report experiencing discrimination when attempting to secure private insurance. This has prompted concern from the German Insurance Association (GDV), which warns that setting fixed time limits could complicate risk assessments for insurers.
The GDV’s general manager, Jörg Asmussen, points out the valid considerations around potential relapses and long-term therapy effects that might arise, affecting the pool of available insurances.
On the other hand, experts like Susanne Weg-Remers from the German Cancer Research Center argue that while some patients develop tumors in other organs, their risk isn’t significantly higher than the general population. With the sobering statistic that one in two men and one in three women in Germany will experience a malignant tumor, she asserts that if insurance policies were based on cancer history, none could be issued.
The German Foundation for Young Adults with Cancer highlights the specific unfairness younger survivors face, stressing that over 16,500 people aged 18 to 39 are diagnosed yearly. Significant medical advancements mean that over 80% of patients in this demographic can be cured.
Meanwhile, the European Society for Medical Oncology advocates for a uniform standard of access to financial services for cancer survivors across Europe. They note that only 11 EU member states have enacted specific laws to protect these individuals, exacerbating the disparities in access to financial services based on geographic location.
An EU directive still in progress would allow for restrictions on insurance based on cancer history for up to 15 years post-treatment, but many feel this insufficient.
Notably, the UK lacks binding RTBF legislation, whereas Ireland has succeeded in passing a law to provide equal footing for mortgage seekers, despite the UK mostly relying on voluntary measures.
Keep in touch with our news & offers
Subscribe to Our Newsletter
Thank you for subscribing to the newsletter.
Oops. Something went wrong. Please try again later.












